source
- AI becomes core to biopharma R&D, driving efficiency and faster drug developmentAI is now regarded as essential to everyday operations in the biopharma sector, helping to reduce the time and cost of drug development. Pfizer CEO Albert Bourla said AI played a key role in integ…
- Novo aims to increase oral Wegovy manufacturing capacity tenfold by 2030Novo announced at its Capital Markets Day that it plans to expand the manufacturing capacity for its oral GLP-1 drug Wegovy by a factor of ten by the end of the decade. The company said about 1.5…